Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

Sherif M Hamdy1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Maged Abdel-Naseer1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Hatem S Shehata1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Amr Hassan1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, EgyptCorrespondence[email protected]

Alaa Elmazny1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Nevin M Shalaby1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Noha T Abokrysha1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Nirmeen A Kishk1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Mona A F Nada1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Sandra M Ahmed1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Mohamed I Hegazy1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Doaa Mekkawy1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Husam S Mourad1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Ahmed Abdelalim1 Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Thomas Berger2 Neurology Department, Medical University of Vienna, Vienna, Austria

Articles from other publishers (9)